A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-dily fluticasone propionate/salmeterol in elderly patients with asthma

A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-dily fluticasone propionate/salmeterol in elderly patients with asthma - The efficacy of fluticasone furoate/vilanterole in elderly asthmatics

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016136

Enrollment

Registered

2015-04-01

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elderly asthma

Interventions

once-daily fluticasone furoate/vilanterole twice-dily fluticasone propionate/salmeterol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stable elderly asthma

Exclusion criteria

Exclusion criteria: Unsle elderly asthma

Design outcomes

Primary

Measure	Time frame
Respiratory functions	—

Countries

Japan

Contacts

Public ContactYoshihisa Ishiura

Toyama City Hospital Respiratory Medicine

ishiura@tch.toyama.toyama.jp076-422-1112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026